company organization
Oxford BioMedica (United Kingdom)
GB
People
Connected researchers
Public evidence
3 connected articles
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMCPrenatal cannabis exposure is associated with alterations in offspring DNA methylation at genes involved in neurodevelopment, across the life course.2025 · Europe PMCAssessing Cannabis Use in People with Psychosis.2024 · Europe PMC
Registered research
Connected studies
Matched by exact identifiers only. Profile data: OpenAlex.